However, regardless of these differences, our findings as described here strongly support the concept that TRIM71 can at least act as a tumor suppressor to repress the growth and migration of ovarian cancer cells (Fig. 5 and 6, and S6) by suppressing mtp53 activity and, consequently, the survival- and metastasis-associated target genes (Fig. 4). The gene discussed is TRIM71; the disease is neoplasm.